Postulates for the evaluation of adverse reactions to drugs

Walter T. Hughes

Research output: Contribution to journalArticle

Abstract

In most large clinical trials, any unexplained adverse event that occurs during the administration of the study drug is considered to be possibly drug-related. While this approach is effective in identifying the adverse effects of a drug, it does not take into account other, non-drug-related factors that may have caused the event. In very few of these clinical trials has there been an attempt to validate that these events are actually drug-induced; yet, they might still be reported as a side effect in the leaflet insert when the drug is later marketed. When such adverse events are erroneously attributed to drug toxicity, allergy, or idiosyncrasy, it couldaffect the clinician’s decision to use that drug. Some patients may therefore be deprivedof a valuable therapeutic tool. Certain postulates should be answered before an adverse effect is considered to be drug-related. It should also be determined whether or not a reaction is due to drugtoxicity rather than to allergy or idiosyncrasy.While all adverse events cannot be put to the same stringent tests, under reasonable and safe circumstances, such practices will allow fora more accurate evaluation of a drug and its suspected adverse effects.

Original languageEnglish (US)
Pages (from-to)179-182
Number of pages4
JournalClinical Infectious Diseases
Volume20
Issue number1
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Drug-Related Side Effects and Adverse Reactions
Pharmaceutical Preparations
Clinical Trials
Drug Hypersensitivity
Drug Evaluation
Hypersensitivity

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)
  • Immunology

Cite this

Postulates for the evaluation of adverse reactions to drugs. / Hughes, Walter T.

In: Clinical Infectious Diseases, Vol. 20, No. 1, 1995, p. 179-182.

Research output: Contribution to journalArticle

Hughes, Walter T. / Postulates for the evaluation of adverse reactions to drugs. In: Clinical Infectious Diseases. 1995 ; Vol. 20, No. 1. pp. 179-182.
@article{88929dd72e0044938335fa21945c1497,
title = "Postulates for the evaluation of adverse reactions to drugs",
abstract = "In most large clinical trials, any unexplained adverse event that occurs during the administration of the study drug is considered to be possibly drug-related. While this approach is effective in identifying the adverse effects of a drug, it does not take into account other, non-drug-related factors that may have caused the event. In very few of these clinical trials has there been an attempt to validate that these events are actually drug-induced; yet, they might still be reported as a side effect in the leaflet insert when the drug is later marketed. When such adverse events are erroneously attributed to drug toxicity, allergy, or idiosyncrasy, it couldaffect the clinician’s decision to use that drug. Some patients may therefore be deprivedof a valuable therapeutic tool. Certain postulates should be answered before an adverse effect is considered to be drug-related. It should also be determined whether or not a reaction is due to drugtoxicity rather than to allergy or idiosyncrasy.While all adverse events cannot be put to the same stringent tests, under reasonable and safe circumstances, such practices will allow fora more accurate evaluation of a drug and its suspected adverse effects.",
author = "Hughes, {Walter T.}",
year = "1995",
doi = "10.1093/clinids/20.1.179",
language = "English (US)",
volume = "20",
pages = "179--182",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Postulates for the evaluation of adverse reactions to drugs

AU - Hughes, Walter T.

PY - 1995

Y1 - 1995

N2 - In most large clinical trials, any unexplained adverse event that occurs during the administration of the study drug is considered to be possibly drug-related. While this approach is effective in identifying the adverse effects of a drug, it does not take into account other, non-drug-related factors that may have caused the event. In very few of these clinical trials has there been an attempt to validate that these events are actually drug-induced; yet, they might still be reported as a side effect in the leaflet insert when the drug is later marketed. When such adverse events are erroneously attributed to drug toxicity, allergy, or idiosyncrasy, it couldaffect the clinician’s decision to use that drug. Some patients may therefore be deprivedof a valuable therapeutic tool. Certain postulates should be answered before an adverse effect is considered to be drug-related. It should also be determined whether or not a reaction is due to drugtoxicity rather than to allergy or idiosyncrasy.While all adverse events cannot be put to the same stringent tests, under reasonable and safe circumstances, such practices will allow fora more accurate evaluation of a drug and its suspected adverse effects.

AB - In most large clinical trials, any unexplained adverse event that occurs during the administration of the study drug is considered to be possibly drug-related. While this approach is effective in identifying the adverse effects of a drug, it does not take into account other, non-drug-related factors that may have caused the event. In very few of these clinical trials has there been an attempt to validate that these events are actually drug-induced; yet, they might still be reported as a side effect in the leaflet insert when the drug is later marketed. When such adverse events are erroneously attributed to drug toxicity, allergy, or idiosyncrasy, it couldaffect the clinician’s decision to use that drug. Some patients may therefore be deprivedof a valuable therapeutic tool. Certain postulates should be answered before an adverse effect is considered to be drug-related. It should also be determined whether or not a reaction is due to drugtoxicity rather than to allergy or idiosyncrasy.While all adverse events cannot be put to the same stringent tests, under reasonable and safe circumstances, such practices will allow fora more accurate evaluation of a drug and its suspected adverse effects.

UR - http://www.scopus.com/inward/record.url?scp=0028835545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028835545&partnerID=8YFLogxK

U2 - 10.1093/clinids/20.1.179

DO - 10.1093/clinids/20.1.179

M3 - Article

VL - 20

SP - 179

EP - 182

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 1

ER -